Researchers from the group of Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modeled the healthy human cervix using organoids. In ...

In this inaugural event we are delighted to feature an exclusive fireside chat with renowned stem cell pioneer and organoid researcher Hans Clevers, MD, PhD, of the Hubrecht Institute in the ...

Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development (pRED) and member of the ...

On 7 September the Körber Foundation will present the Körber European Science Prize 2016 endowed with 750,000 euros to Prof. Dr. Hans Clevers in Hamburg City Hall. The Dutch scientist is honoured for ...

Hans Clevers has always been drawn to scientific blank canvases. “There's a human tendency to ask small questions, where you already know most of the answers, because it feels comfortable to confirm ...

CHICAGO -- The International Society for Stem Cell Research (ISSCR) has awarded Dr. Hans Clevers, senior author on two important papers published recently in the scientific journal Cell, the society's ...

Researchers from the group of Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In ...